Skip to Content

Join the 'Cabometyx' group to help and get support from people like you.

Cabometyx Support Group


Our support group for Cabometyx has 3 questions and 5 members. Updated 14 Feb 2018.

Further Information

Related Condition Support Groups

Renal Cell Carcinoma

Cabometyx Patient Information at

Latest News

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Untreated Advanced Renal Cell Carcinoma

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Dec. 19, 2017-- Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets ...

Read more news...

Latest Questions

View more questions...

Ask a Question